Soft Tissue Injury Medications: What Attorneys Should Know

James Wong — Founder & Pharmacist, LienScripts | November 14, 2025 | 12 min read

Soft tissue injuries are the most common -- and most contested -- injuries in personal injury cases. Understanding the medications prescribed for these injuries helps attorneys anticipate defense arguments, support medical necessity, and build stronger demand packages.

Soft Tissue Injury Medications: What Attorneys Should Know

Soft tissue injuries -- strains, sprains, whiplash, muscle tears, and ligament damage -- account for the vast majority of personal injury cases. They are also the most frequently challenged by insurance adjusters and defense attorneys, who often characterize them as minor, self-limiting, or exaggerated.

The medications prescribed for soft tissue injuries play a critical role in this battle. They document the treating physician's clinical assessment of the injury severity. They demonstrate ongoing medical necessity. And when properly documented, they counter the defense narrative that the injuries are trivial.

For personal injury attorneys, understanding the common medication categories prescribed for soft tissue injuries is not about becoming a pharmacist. It is about knowing enough to evaluate whether your client's treatment is well-documented, to anticipate defense challenges, and to present the medication component of damages with confidence.

[!KEY] The breadth and duration of a soft tissue injury medication regimen is itself evidence of severity — a patient on cyclobenzaprine, meloxicam, and gabapentin for six months tells a very different clinical story than one on OTC ibuprofen for two weeks.

The Most Common Medication Categories for Soft Tissue Injuries

Muscle Relaxants

Muscle relaxants are among the most frequently prescribed medications following motor vehicle accidents and other trauma that causes musculoskeletal injury. They address muscle spasm, which is the body's protective response to injury but which also causes significant pain and limits mobility.

Common muscle relaxants in PI cases:

• Cyclobenzaprine (Flexeril) -- The most widely prescribed muscle relaxant for acute musculoskeletal conditions. Typically prescribed for 2-4 weeks initially, with extensions as clinically indicated.
• Methocarbamol (Robaxin) -- Often used as an alternative to cyclobenzaprine, particularly for patients who experience significant drowsiness with cyclobenzaprine.
• Tizanidine (Zanaflex) -- Prescribed for more severe spasm or when other muscle relaxants have not provided adequate relief. Also used for spasticity associated with spinal injuries.
• Baclofen -- Used for spasm associated with spinal cord or nerve root involvement. Its presence in a medication regimen can indicate more significant neurological involvement.

What attorneys should know: Muscle relaxants prescribed beyond the initial 2-4 week acute period indicate ongoing spasm that has not resolved -- evidence that the soft tissue injury is more significant than a simple strain. If the prescriber extends the muscle relaxant or increases the dose, this supports a claim of sustained injury severity.

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

NSAIDs address both pain and inflammation, making them a cornerstone of soft tissue injury treatment. They are often the first medication prescribed and may continue throughout the treatment period.

Common NSAIDs in PI cases:

• Meloxicam (Mobic) -- A once-daily prescription NSAID commonly prescribed for musculoskeletal injuries. Its long duration of action makes it convenient for consistent anti-inflammatory coverage.
• Naproxen (Naprosyn) -- Available in prescription strength, naproxen provides sustained anti-inflammatory effect and is well-tolerated by most patients.
• Diclofenac -- Available in oral form and as a topical gel (Voltaren). The topical formulation is particularly common in PI cases for localized pain without the systemic side effects of oral NSAIDs.
• Celecoxib (Celebrex) -- A COX-2 selective NSAID prescribed for patients who cannot tolerate traditional NSAIDs due to gastrointestinal sensitivity. Its prescription often indicates that the patient has been on anti-inflammatory therapy long enough to develop GI concerns -- further evidence of sustained treatment need.

What attorneys should know: The progression from over-the-counter NSAIDs (ibuprofen, naproxen) to prescription-strength formulations indicates that the injury required more aggressive anti-inflammatory management than self-treatment could provide. If the prescriber switches from one NSAID to another, it typically means the first agent was insufficient -- not that the medication was unnecessary.

Nerve Pain Medications (Neuropathic Agents)

When soft tissue injuries involve nerve compression, irritation, or radiculopathy, the prescriber may add neuropathic pain agents to the regimen. The presence of these medications in the treatment plan is clinically significant because it indicates neurological involvement beyond simple muscle or ligament injury.

Common nerve pain medications in PI cases:

• Gabapentin (Neurontin) -- The most commonly prescribed neuropathic agent in personal injury cases. Typically started at a low dose and titrated upward, gabapentin is indicated for nerve pain associated with cervical or lumbar radiculopathy.
• Pregabalin (Lyrica) -- Similar mechanism to gabapentin but with more consistent absorption. Often prescribed when gabapentin has not provided adequate relief or when the prescriber prefers a more predictable dose-response.
• Duloxetine (Cymbalta) -- An SNRI antidepressant that is also FDA-approved for chronic musculoskeletal pain. Its presence in a PI medication regimen indicates chronic pain that has not resolved with first-line treatments.

What attorneys should know: The addition of a nerve pain medication to the treatment regimen is one of the strongest indicators that a soft tissue injury has progressed beyond a simple strain. Defense attorneys who argue that the injuries are minor must contend with the fact that the treating physician identified neurological symptoms significant enough to warrant neuropathic medication. This is powerful evidence of injury severity.

[!KEY] A soft tissue case where gabapentin or pregabalin appears in the pharmacy record alongside a muscle relaxant and NSAID has documented three independently prescribed drug classes — each representing a physician's clinical finding of a distinct injury component — making the multi-medication regimen itself a powerful damages exhibit that the defense cannot dismiss without attacking each prescribing decision separately.

Topical Pain Medications

Topical medications deliver pain relief directly to the affected area and are increasingly common in personal injury treatment plans. They include both commercially manufactured products and custom-compounded formulations.

Common topical medications in PI cases:

• Diclofenac gel (Voltaren) -- A topical NSAID that provides localized anti-inflammatory effect
• Lidocaine patches (Lidoderm) -- Provide localized numbing for specific pain areas, commonly used for neck and back injuries
• Compounded topical creams -- Custom formulations that may combine multiple active ingredients (e.g., ketamine, gabapentin, diclofenac, cyclobenzaprine) in a topical base for targeted delivery

What attorneys should know: Topical medications are sometimes challenged by defense adjusters as unnecessary additions to an oral medication regimen. The clinical rationale is straightforward: topical delivery provides targeted relief with fewer systemic side effects, allowing patients to reduce their reliance on oral medications. For patients who cannot tolerate oral NSAIDs or who need localized relief in addition to systemic treatment, topicals serve a distinct clinical purpose.

However, attorneys should be aware that compounded topical medications can carry significantly higher costs than commercially manufactured alternatives. Understanding the pricing structure of these compounds and ensuring they are clinically justified is important for maintaining the credibility of the medication claim.

Opioid Pain Medications

While the trend in personal injury treatment has moved away from long-term opioid prescribing, short-term opioid use remains clinically appropriate for acute pain management following trauma.

Common opioids in PI cases:

• Tramadol -- A lower-potency opioid often used as a step between NSAIDs and stronger pain medications
• Hydrocodone/acetaminophen (Norco, Vicodin) -- The most commonly prescribed opioid for moderate to severe acute pain following injury
• Oxycodone -- Prescribed for more severe pain, typically in the immediate post-injury period

What attorneys should know: Short-term opioid prescriptions (1-2 weeks) following acute trauma are clinically standard and rarely challenged. If opioid prescriptions extend beyond the acute period, ensure that the medical records document ongoing pain severity that justifies continued use and that the prescriber has explored or is transitioning to non-opioid alternatives.

[!NOTE] The addition of a nerve pain medication to a soft tissue regimen is one of the strongest indicators that an injury has progressed beyond a simple strain — it documents that the treating physician identified neurological symptoms significant enough to require neuropathic pharmacological intervention.

How Medications Support the Injury Claim

Documenting Injury Severity

The medication regimen itself is evidence of injury severity. A patient prescribed only ibuprofen for two weeks has a different injury profile than a patient prescribed cyclobenzaprine, meloxicam, gabapentin, and a topical compound for six months. The breadth, duration, and escalation of the medication regimen tells a clinical story about how serious the injuries are.

Establishing Treatment Necessity

Each prescription filled is a clinical decision by a licensed physician that the medication was medically necessary. When a physician prescribes gabapentin for a whiplash patient, they are making a professional judgment that the patient's symptoms include a neuropathic component that requires specific pharmacological intervention. This is not casual or arbitrary -- it is a clinical determination documented in the medical record.

Creating a Treatment Timeline

Consistent prescription fills create a timeline that demonstrates ongoing medical need. When an adjuster argues that the patient should have recovered within six weeks, a medication timeline showing prescriptions continuing for four months -- with consistent refills and no gaps -- directly contradicts that assertion.

Common Defense Arguments and How to Counter Them

"The Medications Were Not Necessary"

The argument: The defense claims that the prescriptions were excessive, that over-the-counter alternatives would have been sufficient, or that the medications were prescribed for convenience rather than medical necessity.

The counter: A pharmacist-signed clinical narrative explaining the pharmacological rationale for each prescription directly addresses this argument. The narrative should explain why prescription-strength medications were required over OTC alternatives, why each drug class was necessary for the specific symptoms presented, and how the medication regimen aligned with clinical treatment guidelines.

"The Treatment Was Excessive or Prolonged"

The argument: The defense argues that the duration of medication use was longer than clinically necessary, suggesting that the patient was overtreating or that the prescriber was not managing the case appropriately.

The counter: Document the clinical justification for the treatment duration. If the prescriber extended a medication beyond the initial course, the medical record should reflect why -- persistent symptoms, failed attempts to taper, new symptoms developing, or transition to different treatment modalities. A chronological medication timeline showing gradual tapering (reduced doses or less frequent refills) toward the end of treatment demonstrates medically appropriate wind-down rather than abrupt discontinuation.

"These Are Pre-Existing Conditions"

The argument: The defense claims that the medications were prescribed for pre-existing conditions, not injuries from the incident.

The counter: If the patient had no prescription history for these medication classes before the incident, the medical records will show that. If the patient was taking similar medications before the incident, the attorney should document the change in dosage, frequency, or drug type following the injury -- showing that the incident exacerbated the condition and required different or additional pharmacological management.

"The Costs Are Unreasonable"

The argument: The defense challenges the pricing of the medications as inflated or above market rates.

The counter: Work with a pharmacy benefit provider whose pricing methodology is documented, consistent, and available for review. When the charges are backed by a complete dispensing record and a pharmacist-signed clinical narrative, the cost challenge loses its force.

Practical Recommendations for Attorneys

Learn the Basic Drug Classes

You do not need a pharmacy degree, but knowing the difference between a muscle relaxant and a nerve pain medication -- and understanding what each category signals about injury severity -- makes you a more effective advocate.

Review Medication Records Early

Do not wait until demand preparation to review the medication records. Reviewing them during the case allows you to:

• Identify potential documentation gaps early
• Discuss medication changes with the treating physician
• Ensure the treatment regimen is well-supported in the medical record
• Flag any medications that might be challenged and prepare counter-arguments

Request a POGOS Report

A POGOS report provides the pharmacist-signed clinical narrative that ties the entire medication regimen together. For any case where medications are a significant component of damages, a POGOS report is the most efficient way to strengthen the medication documentation.

[!KEY] Reviewing the medication records during the case — not just at demand preparation — allows attorneys to identify prescribing patterns that warrant documentation, escalations that should be connected to clinical milestones in the treatment notes, and gaps that can still be addressed while treatment is ongoing.

Coordinate with the Prescriber

Ensure that the treating physician's notes explicitly connect each prescription to the injury. Notes that simply say "Rx: cyclobenzaprine 10mg #30" are clinically valid but do not tell the treatment story as effectively as notes that say "Patient presents with persistent cervical paraspinal spasm consistent with whiplash injury sustained on [date]. Prescribing cyclobenzaprine 10mg for muscle spasm management."

The Bottom Line

Soft tissue injuries may be the most common injuries in personal injury, but that does not make them simple to litigate. The medications prescribed for these injuries are clinically meaningful, and when properly documented, they serve as powerful evidence of injury severity, treatment necessity, and ongoing medical need.

Attorneys who understand these medications -- what they treat, why they are prescribed, and how they support the claim -- are better equipped to build strong demand packages, counter defense arguments, and maximize settlement value for their clients.

Learn how LienScripts supports attorneys with comprehensive medication documentation for every soft tissue injury case.

Related Resources

• Cyclobenzaprine -- Drug information for the most common muscle relaxant in PI cases
• Meloxicam -- Drug information for a widely prescribed anti-inflammatory
• Gabapentin -- Drug information for the leading nerve pain medication
• Clinical Narratives and Medical Necessity -- How pharmacist narratives counter overtreatment arguments
• Pharmacy Services for Personal Injury Clients: How It Works — How pharmacy liens provide $0 upfront medication access for PI patients
• What Are Medication Liens? — Glossary guide explaining medication liens and how they differ from pharmacy liens